Schizophreniform Disorder

White Matter Abnormalities and Clinical Symptom Severity in Schizophrenia

White Matter Abnormalities and Clinical Symptom Severity in Schizophrenia

By

New findings provide an insight about the association between white matter microstructure and the severity of schizophrenia clinical symptoms.

Neuroinflammation in Schizophrenia: New PET Brain Imaging Studies

Neuroinflammation in Schizophrenia: New PET Brain Imaging Studies

By

TSPO expression is frequently used as a biomarker for brain inflammation during PET imaging.

Molecular Abnormalities in the Hippocampus in Schizophrenia

Molecular Abnormalities in the Hippocampus in Schizophrenia

By

Post mortem examination of human brain samples derived from individuals diagnosed with schizophrenia revealed widespread synaptic alterations in CA1 hippocampal subfield.

Early Biomarkers Identified in Schizophrenia Preclinical Model

Early Biomarkers Identified in Schizophrenia Preclinical Model

By

New findings provide insights about the neuroanatomy and neurophysiology of schizophrenia.

Sign Up for Free e-newsletters